BDBM329701 Cis-4-(1-(2-chloro- 6- (trifluoromethyl)benzoyl)-4-fluoro-1H- indazol-3- ylamino)cyclohexane- carboxylic acid::US9663522, 1H

SMILES OC(=O)[C@@H]1CC[C@@H](CC1)Nc1nn(C(=O)c2c(Cl)cccc2C(F)(F)F)c2cccc(F)c12

InChI Key InChIKey=JQUXYDMRKKPCTA-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 329701   

TargetNuclear receptor ROR-gamma(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM329701(US9663522, 1H | Cis-4-(1-(2-chloro- 6- (trifluorom...)
Affinity DataIC50: 6.17E+3nMAssay Description:The compounds of the invention inhibit RORgammaT activity. Activation of RORgammaT activity can be measured using, e.g., biochemical TR-FRET assay. I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent